Brief description of the instructions for Teriflunomide Tablets (Aubagio)

Teriflunomide tablets, an immunomodulator for multiple sclerosis, bring new treatment options to patients with its unique anti-inflammatory properties. This drug blocks the activity of dihydroorotate dehydrogenase, thereby affecting the initial production of pyrimidines, and regulates the production of DNA and RNA in the body. In clinical trials, teriflunomide has been shown to have a significant effect on reducing areas of active MS lesions in the brain. Although its exact mechanism of action is not fully understood, it is generally thought to reduce the number of white blood cells activated by foreign antigens in the central nervous system. This article will briefly describe the instructions for use of Teriflunomide Tablets (Aubagio).

1. Drug information

Generic name: Teriflunomide tablets

Product name:Aubagio

English name:Teriflunomide Tablets

2. Ingredients

The chemical name of Teriflunomide is(Z)-2-oxy-3-hydroxy-2-butene-(4-trifluoromethyl-phenyl)acyl waste, its molecular formula is C12HF3N2O2, and its molecular weight is 270.21.

3. Dosage forms and specifications

Teriflunomide tablets are available in two specifications: 7 mg and 14 mg. The color and shape of the tablets are specifically marked to facilitate patients' identification.

4. Indications

This product is suitable for the treatment of relapsing multiple sclerosis and provides patients with a new treatment approach.

5. Usage and dosage

Oral once a day, the dosage is 7mg or 14mg. It can be taken before, after or with meals according to the patient's condition. The specific usage and dosage should be followed the doctor’s advice.

6. Precautions for use

1. Inform the doctor about allergies, disease history and medications you are taking.

2. Patients over 60 years old should use with caution.

3. You may be more susceptible to infection during medication, so you need to pay attention to personal hygiene.

4. Bleeding may be more likely during medication, so injuries should be avoided.

5. Liver function tests need to be performed before and after medication, and ALT levels should be monitored regularly.

7. Adverse reactions

Possible adverse reactions when using this product include hepatotoxicity, infection, hypersensitivity reactions, severe skin reactions, etc. In addition, symptoms such as diarrhea, stomach upset, and hair loss may also occur.

8. Other information

Teriflunomide tablets have been launched in China and are included in medical insurance. Patients can consult the local medical insurance bureau for detailed information. At the same time, generic versions of drugs are also sold in the Indian market, and the prices are more affordable. However, when purchasing, you need to ensure that the channels are formal to ensure the quality and safety of the drugs.

The above information is for reference only. Please strictly follow the doctor's instructions when using this product. If you have any questions or discomfort, please consult your doctor or pharmacist in time.